Search research articles
Contact Us
Filters
Showing results (161-170 of 287) with videos related to
Page
of 29
Sort By:
Circulation
|
August 10, 2011
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008
Brent M Egan, Yumin Zhao, R Neal Axon, et al.
Journal of Clinical Lipidology
|
July 24, 2019
Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials
Keith C Ferdinand, Terry A Jacobson, Andrew Koren, et al.
Cardiovascular Diabetology
|
March 9, 2023
Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes
Keith C Ferdinand, Julia Dunn, Claudia Nicolay, et al.
Journal of the American Society of Hypertension : JASH
|
March 19, 2011
Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension
Keith C Ferdinand, Richard Weitzman, Marc Israel, et al.
American Journal of Preventive Cardiology
|
March 31, 2025
Combating cardiovascular disease disparities: The potential role of artificial intelligence
Chisom J Orakwue, Farbod Zahedi Tajrishi, Constance M Gistand, et al.
Current Hypertension Reports
|
March 20, 2026
Low-Dose Aspirin Recommendations for Preeclampsia Risk Reduction: A Systematic Review Focused on Black Patients : Current Hypertension Reports
Yitian Zha, Natalie J Mikhailov, Krishna H Brucia, et al.
Current Cardiology Reports
|
September 5, 2024
Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults
Tina K Reddy, Samar A Nasser, Anuhya V Pulapaka, et al.
American Journal of Preventive Cardiology
|
July 30, 2021
Response to the letter to the editor by Silverman-Lloyd et al. entitled: "Race is not a risk factor: Reframing discourse on racial health inequities in CVD prevention"
Erin D Michos, Keith C Ferdinand, LaPrincess C Brewer, et al.
Journal of the National Medical Association
|
March 27, 2026
Addressing disparities in transthyretin amyloid cardiomyopathy: A systematic review of artificial intelligence in the early identification to improve patient outcomes
Zihuang Zhang, Natalie Lim, Joe Abi-Rached, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 9, 2014
RESPONSE TO 190678: TO TREAT OR NOT TO TREAT SHOULD NO LONGER BE THE QUESTION
Anbesaw Selassie, Shaun Wagner, Marilyn L Laken, et al.
Page
of 29
Search research articles
Search
Showing results (161-170 of 287) with videos related to
Sort By:
Page
of 29
Circulation
|
August 10, 2011
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008
Brent M Egan, Yumin Zhao, R Neal Axon, et al.
Journal of Clinical Lipidology
|
July 24, 2019
Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials
Keith C Ferdinand, Terry A Jacobson, Andrew Koren, et al.
Cardiovascular Diabetology
|
March 9, 2023
Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes
Keith C Ferdinand, Julia Dunn, Claudia Nicolay, et al.
Journal of the American Society of Hypertension : JASH
|
March 19, 2011
Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension
Keith C Ferdinand, Richard Weitzman, Marc Israel, et al.
American Journal of Preventive Cardiology
|
March 31, 2025
Combating cardiovascular disease disparities: The potential role of artificial intelligence
Chisom J Orakwue, Farbod Zahedi Tajrishi, Constance M Gistand, et al.
Current Hypertension Reports
|
March 20, 2026
Low-Dose Aspirin Recommendations for Preeclampsia Risk Reduction: A Systematic Review Focused on Black Patients : Current Hypertension Reports
Yitian Zha, Natalie J Mikhailov, Krishna H Brucia, et al.
Current Cardiology Reports
|
September 5, 2024
Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults
Tina K Reddy, Samar A Nasser, Anuhya V Pulapaka, et al.
American Journal of Preventive Cardiology
|
July 30, 2021
Response to the letter to the editor by Silverman-Lloyd et al. entitled: "Race is not a risk factor: Reframing discourse on racial health inequities in CVD prevention"
Erin D Michos, Keith C Ferdinand, LaPrincess C Brewer, et al.
Journal of the National Medical Association
|
March 27, 2026
Addressing disparities in transthyretin amyloid cardiomyopathy: A systematic review of artificial intelligence in the early identification to improve patient outcomes
Zihuang Zhang, Natalie Lim, Joe Abi-Rached, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 9, 2014
RESPONSE TO 190678: TO TREAT OR NOT TO TREAT SHOULD NO LONGER BE THE QUESTION
Anbesaw Selassie, Shaun Wagner, Marilyn L Laken, et al.
Page
of 29